Molecular analysis of HIV type 1 vif sequences from Cape Town, South Africa
dc.contributor.author | Jacobs G.B. | |
dc.contributor.author | Nistal M. | |
dc.contributor.author | Laten A. | |
dc.contributor.author | Van Rensburg E.J. | |
dc.contributor.author | Rethwilm A. | |
dc.contributor.author | Preiser W. | |
dc.contributor.author | Bodem J. | |
dc.contributor.author | Engelbrecht S. | |
dc.date.accessioned | 2011-05-15T16:03:21Z | |
dc.date.available | 2011-05-15T16:03:21Z | |
dc.date.issued | 2008 | |
dc.description.abstract | South Africa has the highest number of HIV-1-infected individuals in the world, with HIV-1 subtype C prevailing. However, HIV-1 subtype C accessory genes are rarely characterized in the country. These genes are important for establishing viral pathogenesis. The Vif protein has been shown to counteract the antiretroviral activity of APOBEC3G/F cytidine deaminases. In this study an additional 50 HIV-1 vif sequences are characterized. These include 48 HIV-1 subtype C and 2 HIV-1 subtype B sequences. Highly conserved HIV-1 subtype C motifs are outlined. The previously identified RLRR (90-93) motif does not seem to be conserved among our newly analyzed sequences. Conserved motifs can be useful for developing new vaccine strategies or antiretroviral drugs. © 2007 Mary Ann Liebert, Inc. | |
dc.description.version | Article | |
dc.identifier.citation | AIDS Research and Human Retroviruses | |
dc.identifier.citation | 24 | |
dc.identifier.citation | 7 | |
dc.identifier.issn | 8892229 | |
dc.identifier.other | 10.1089/aid.2008.0077 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/12587 | |
dc.subject | apolipoprotein B messenger RNA editing enzyme catalytic polypeptide 3F | |
dc.subject | apolipoprotein B messenger RNA editing enzyme catalytic polypeptide 3G | |
dc.subject | Vif protein | |
dc.subject | amino acid sequence | |
dc.subject | article | |
dc.subject | clinical article | |
dc.subject | controlled study | |
dc.subject | female | |
dc.subject | human | |
dc.subject | Human immunodeficiency virus 1 | |
dc.subject | Human immunodeficiency virus 1 infection | |
dc.subject | male | |
dc.subject | nucleotide sequence | |
dc.subject | phylogenetic tree | |
dc.subject | polymerase chain reaction | |
dc.subject | priority journal | |
dc.subject | protein motif | |
dc.subject | sequence analysis | |
dc.subject | South Africa | |
dc.subject | unindexed sequence | |
dc.subject | virus pathogenesis | |
dc.subject | Amino Acid Motifs | |
dc.subject | Amino Acid Sequence | |
dc.subject | Female | |
dc.subject | Gene Products, vif | |
dc.subject | HIV Infections | |
dc.subject | HIV-1 | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Molecular Sequence Data | |
dc.subject | Sequence Alignment | |
dc.subject | South Africa | |
dc.title | Molecular analysis of HIV type 1 vif sequences from Cape Town, South Africa | |
dc.type | Article |